Clinical trial

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

NCT07567846

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-04-29

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2026-04-29Date precision: day

Registry last updated2026-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Prostate Cancerunresolved

Metastatic Prostate Cancerunresolved

Interventions

GDC-1261DRUG

Sponsors & collaborators

Genentech, Inc.lead sponsor

Mapped research locations

NashvilleTennessee, United States1 ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07567846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.